Spironolactone for Secondary Central Serous Chorioretinopathy: A Challenge-Rechallenge Case
Central serous chorioretinopathy (CSCR) is potentially sight-threatening and has been associated with corticosteroid use. CSCR secondary to steroid use can sometimes be challenging to treat, especially if continuing steroid use is medically necessary. In this case report we demonstrate the efficacy...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2017-07-01
|
Series: | Case Reports in Ophthalmology |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/477757 |
_version_ | 1818559251631570944 |
---|---|
author | Kapil G. Kapoor Jennifer Sim |
author_facet | Kapil G. Kapoor Jennifer Sim |
author_sort | Kapil G. Kapoor |
collection | DOAJ |
description | Central serous chorioretinopathy (CSCR) is potentially sight-threatening and has been associated with corticosteroid use. CSCR secondary to steroid use can sometimes be challenging to treat, especially if continuing steroid use is medically necessary. In this case report we demonstrate the efficacy of spironolactone as an effective agent in countering CSCR secondary to steroid use. This challenge-rechallenge case may be helpful to clinicians in delineating a treatment paradigm for these patients. |
first_indexed | 2024-12-14T00:22:59Z |
format | Article |
id | doaj.art-a7d48e39f0e4474898d8ca92cbb4154d |
institution | Directory Open Access Journal |
issn | 1663-2699 |
language | English |
last_indexed | 2024-12-14T00:22:59Z |
publishDate | 2017-07-01 |
publisher | Karger Publishers |
record_format | Article |
series | Case Reports in Ophthalmology |
spelling | doaj.art-a7d48e39f0e4474898d8ca92cbb4154d2022-12-21T23:25:09ZengKarger PublishersCase Reports in Ophthalmology1663-26992017-07-018237037410.1159/000477757477757Spironolactone for Secondary Central Serous Chorioretinopathy: A Challenge-Rechallenge CaseKapil G. KapoorJennifer SimCentral serous chorioretinopathy (CSCR) is potentially sight-threatening and has been associated with corticosteroid use. CSCR secondary to steroid use can sometimes be challenging to treat, especially if continuing steroid use is medically necessary. In this case report we demonstrate the efficacy of spironolactone as an effective agent in countering CSCR secondary to steroid use. This challenge-rechallenge case may be helpful to clinicians in delineating a treatment paradigm for these patients.http://www.karger.com/Article/FullText/477757Central serous chorioretinopathySpironolactoneCorticosteroids |
spellingShingle | Kapil G. Kapoor Jennifer Sim Spironolactone for Secondary Central Serous Chorioretinopathy: A Challenge-Rechallenge Case Case Reports in Ophthalmology Central serous chorioretinopathy Spironolactone Corticosteroids |
title | Spironolactone for Secondary Central Serous Chorioretinopathy: A Challenge-Rechallenge Case |
title_full | Spironolactone for Secondary Central Serous Chorioretinopathy: A Challenge-Rechallenge Case |
title_fullStr | Spironolactone for Secondary Central Serous Chorioretinopathy: A Challenge-Rechallenge Case |
title_full_unstemmed | Spironolactone for Secondary Central Serous Chorioretinopathy: A Challenge-Rechallenge Case |
title_short | Spironolactone for Secondary Central Serous Chorioretinopathy: A Challenge-Rechallenge Case |
title_sort | spironolactone for secondary central serous chorioretinopathy a challenge rechallenge case |
topic | Central serous chorioretinopathy Spironolactone Corticosteroids |
url | http://www.karger.com/Article/FullText/477757 |
work_keys_str_mv | AT kapilgkapoor spironolactoneforsecondarycentralserouschorioretinopathyachallengerechallengecase AT jennifersim spironolactoneforsecondarycentralserouschorioretinopathyachallengerechallengecase |